Events & News

Valid Insight Market Access
Carolyn Steeds featured in the 2nd Edition of Medical Writing in HEOR/Market Access Guide

The second edition of the medical writing in HEOR/Market Access careers guide was launched in June 2019.  This guide focuses on medical writing roles in the HEOR/market access arenas, but will be of interest to anyone who wants to understand more about the business of ensuring access to new medicines and devices for patients. If you have […]

Valid Insight Market Access
Press Release: Valid Insight wins the Queen’s Most Coveted Award for Enterprise

The Queen’s Awards for Enterprise are the UK’s most esteemed business awards, presented only to the most eminent of companies or individuals, demonstrating outstanding results in their field. Today, Her Majesty the Queen announced approval of the Prime Minister’s recommendation for Valid Insight to be honoured in recognition of the outstanding success of the company’s […]

Valid Insight Team Raising Funds for Charity
Rattling the tins: Valid Insight collects donations for Leuka

Leukaemia is the 12th most common cancer in Europe, and the 11th most common worldwide. Leuka is a specialist leukaemia charity (now part of Leukaemia UK), investing in the next generation of leukaemia research talent in the UK and beyond. In 2017, Leuka raised nearly £1 million for research, and awarded £2.2 million to blood […]

specialist global market access consultancy
Valid Insight joins the Scottish Life Sciences Association

Valid Insight, a specialist global market access consultancy firm with Europe based staff, including London, Belgium and Scotland, has joined the Scottish Lifesciences Association, in order to develop its role in life sciences in the region’s hubs, and to support the fast-growing local industry. “SLA is the voice of Scotland’s vibrant life sciences industries to […]

Market Access Experts
Valid Insight welcomes Frank Cousins as Senior Director

Valid Insight, the specialist global market access consultancy, are excited to announce that we have appointed Frank Cousins as Senior Director. Frank has over 20 years’ experience as a consultant to the pharmaceutical industry, specialising in the integration of regulatory strategy, evidence generation and market access for optimal launch and commercial planning. Frank Cousins will […]

Pharma Market Access Consultancy
We are recruiting

As a rapidly growing pharma market access consultancy, Valid Insight are looking for high calibre senior individuals to join us on our journey. If you are passionate about market access, with demonstrable knowledge and experience in delivering international projects that make a difference, we’d love to hear from you. To learn more about what we […]

Valid Insight Market Access
Valid Insight’s new appointments confirm its strength in market access and value

LONDON, UK – Just 18 months after its February 2016 launch, market access consultancy Valid Insight is pleased to announce the appointment of two new senior people to its rapidly expanding team. Dominic Jones-Phillips and James Wright bring decades of specialist experience from industry. Dominic Jones-Phillips and James Wright will lead global pricing, reimbursement, and […]

Pharma Market Access Consultancy
We’re going from strength to strength – want to join us?

Current vacancies:  Director, Market Access & Pricing Principal Consultant, Market Access & Pricing Senior Market Access & Payer Research Consultant Location: Europe-wide As a rapidly growing Pharma Market Access Consultancy, Valid Insight are looking for high calibre senior individuals to join us on our journey. If you are passionate about Market Access, with demonstrable knowledge […]

Market Access Experts
Announcing the launch of Valid Insight

Dr Steve Bradshaw, leading a team of key life science advisors and market access experts, has launched Valid Insight, a new market access consultancy created to help companies navigate the challenges faced by drug developers seeking market access for new and innovative therapeutics. Getting a new drug to market and to patients who need better medicines […]